New Paper Published: Plasma S100β is a Predictor for Pathology and Cognitive Decline in Alzheimer’s Disease

This study highlights plasma S100β as a promising non-invasive biomarker for early detection and progression monitoring of Alzheimer’s disease. Given its strong association with cognitive decline and AD pathology, S100β could serve as a valuable diagnostic tool, addressing the urgent need for accessible biomarkers to guide early interventions and treatment strategies.

View Publication

Recent Posts

Valerie featured in UKNow

UKNow featured Valerie and her participation in the Sanders-Brown Center on Aging NIH-funded Kentucky Alzheimer’s Disease Postbaccalaureate Research Education Program (KYAD-PREP). The program provided Valerie with mentored research experience in Alzheimer’s disease and related disorders before beginning her PhD training at UK. Read the full story in UKNow.

Read More »
September 23, 2026

Suelen joins BHL

Suelen Santos Alves has joined BHL as a Postdoctoral Scholar. Originally from Brazil, Suelen will contribute to the lab’s research on blood-brain barrier dysfunction in Alzheimer’s disease with epilepsy. Welcome to the BHL, Suelen!

Read More »
September 14, 2026

Pannita joins BHL as a Fulbright Scholar

Pannita Holasut has joined the BHL as a Fulbright-National Research Council of Thailand Junior Research Scholar. Supported by the Thailand-United States Educational Foundation (TUSEF), Pannita will conduct research in the BHL as part of her Fulbright fellowship.

Read More »
September 1, 2026